ArticleClinical drug investigation2026

Risk of Neurological Adverse Events Between PD-L1 and PD-1 Inhibitors in South Korean Patients with Lung Cancer: A Target Trial Emulation Framework.

Sang Hee Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.